Author:
Tavridou Anna,Kaklamanis Loukas,Megaritis George,Kourounakis Angeliki P.,Papalois Apostolos,Roukounas Dimitris,Rekka Eleni A.,Kourounakis Panos N.,Charalambous Avgui,Manolopoulos Vangelis G.
Reference45 articles.
1. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia;Amano;Eur. J. Pharmacol.,2003
2. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis;Amin;J. Lipid Res.,1992
3. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase;Amin;J. Pharmacol. Exp. Ther.,1997
4. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo;Baxter;J. Biol. Chem.,1992
5. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase;Bergstrom;Proc. Natl. Acad. Sci. U. S. A.,1993
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献